Zeer MMS / intent / mms

MMS

501-1000 employees·Canton, Michigan, United States·mmsholdings.com

Observed, not inferred · updated weekly

Buying intent

52 tracked signals | Top 15 topics are below | Sales and Engineering are carrying most of it.

44signals · 30 days
23topics tracked
43.75%attributed to a team

Attention by team

LinkedIn activity, by team

Where MMS's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Pharmaceutical
Clinical Trials
Clinical Data Management
Career Development
Artificial Intelligence
Hiring
Sales
Medium25% of team Sales to Pharmaceutical: Medium, 25% of this team's signals
Medium25% of team Sales to Clinical Trials: Medium, 25% of this team's signals
Medium25% of team Sales to Clinical Data Management: Medium, 25% of this team's signals
Sales to Career Development: no signal
Medium25% of team Sales to Artificial Intelligence: Medium, 25% of this team's signals
Sales to Hiring: no signal
Engineering
Engineering to Pharmaceutical: no signal
Low33% of team Engineering to Clinical Trials: Low, 33% of this team's signals
Low33% of team Engineering to Clinical Data Management: Low, 33% of this team's signals
Low33% of team Engineering to Career Development: Low, 33% of this team's signals
Engineering to Artificial Intelligence: no signal
Engineering to Hiring: no signal
HR
Low50% of team HR to Pharmaceutical: Low, 50% of this team's signals
HR to Clinical Trials: no signal
HR to Clinical Data Management: no signal
HR to Career Development: no signal
HR to Artificial Intelligence: no signal
Low50% of team HR to Hiring: Low, 50% of this team's signals
Operations
Operations to Pharmaceutical: no signal
Operations to Clinical Trials: no signal
Operations to Clinical Data Management: no signal
Operations to Career Development: no signal
Low100% of team Operations to Artificial Intelligence: Low, 100% of this team's signals
Operations to Hiring: no signal
Others
High28% of team Others to Pharmaceutical: High, 28% of this team's signals
High28% of team Others to Clinical Trials: High, 28% of this team's signals
Medium17% of team Others to Clinical Data Management: Medium, 17% of this team's signals
Medium17% of team Others to Career Development: Medium, 17% of this team's signals
Others to Artificial Intelligence: no signal
Medium11% of team Others to Hiring: Medium, 11% of this team's signals
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Pharmaceutical
LinkedIn
High volume
97%
last
18d ago
Clinical Trials
LinkedIn
High volume
95%
last
18d ago
Clinical Data Management
LinkedIn
High volume
98%
last
19d ago
Career Development
LinkedIn
Medium volume
95%
last
24d ago
Artificial Intelligence
LinkedIn
Medium volume
96%
last
18d ago
Hiring
LinkedIn
Medium volume
98%
last
19d ago
Conference
LinkedIn
Low volume
98%
last
18d ago
Thermo Fisher Scientific
LinkedIn
Low volume
98%
last
26d ago
Data Science
LinkedIn
Low volume
97%
last
18d ago
ICON PLC
LinkedIn
Low volume
98%
last
31d ago
Drug Development
LinkedIn
Low volume
96%
last
18d ago
Professional Development
LinkedIn
Low volume
98%
last
24d ago
Data Quality
LinkedIn
Low volume
96%
last
20d ago
Data Visualization
LinkedIn
Low volume
98%
last
19d ago
Future of Work
LinkedIn
Low volume
98%
last
27d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at MMS

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others5 active
Leadershipresearching Clinical Trials
in
VPresearching Pharmaceutical
in
Directorresearching Quality Management
in
researching Clinical Data Management
in
researching Career Development
in
Sales4 active
Directorresearching Pharmaceutical
in
Directorresearching Data Visualization
in
researching Pharmaceutical
in
Engineering1 active
researching Clinical Trials
in
HR1 active
Manager, Talent Acquisition
Senior ICresearching Hiring
in
+ 1 more in HR
Operations1 active
Sr.Director, Regional Business Operations and Development (India)
Directorresearching Artificial Intelligence
in
+ 1 more in Operations

See everyone, not just the first 10

12 people across every department at MMS, plus a LinkedIn profile link for each.

Primary products / business lines

LinkedIn company profile

MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, a 20-year track record, AI technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO part

New capability sought

Employee posts (LinkedIn)

Hiring; Conference; Data Science; Thermo Fisher Scientific

Top accounts researching MMS

names withheld on the public page

These are companies whose own people brought up MMS unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

6,459 companies · 25,813 people are researching Pharmaceutical

MMS's own team shows 8 signals on this topic. No one outside MMS has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.

  • Clinical Trials4,086 cos · 17,225 people
  • Clinical Data Management210 cos · 761 people
Sign up to see which companies →

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching MMS.

Company size breakdown
Buyer seniority mix

Sign up to learn more

Create an account to explore buyer insights as they become available.

Sign up to learn more →

Buying committee functions

Employee job titles (LinkedIn)

Sales — 4 people; HR / Talent — 2 people; Engineering — 1 person; Operations — 1 person; Leadership — 1 person

What's been said

public posts by MMS's team

No public post naming MMS has surfaced in the past year, so this is what MMS's own team is posting about publicly — their topics, in their words.

LinkedInExecutive Presence

Every time the Roman emperor Marcus Aurelius returned victorious from war, amidst all the applause, celebrations, and praise, an attendant would whisper just five words into his ear: “Remember, you will die one day.” And remarkably, Marcus himself had instructed the attendant to do this. Not to be morbid. Not to diminish success. But to stay grounded. The Stoics called it Memento Mori — remembering that life is temporary. In today’s corporate world, this principle feels more relevant than ever. Titles change. Cabins change. Org charts change. Power shifts. The people applauding you today may move on tomorrow. And somewhere in the race for targets, promotions, visibility, and recognition, many leaders unknowingly lose something far more valuable: their humility, their relationships, their kindness, their humanity. When we remember that all of us are temporary visitors in this journey called life, something shifts. Egos become smaller. Listening becomes easier. Gratitude becomes deeper. People matter more than positions. Ironically, the leaders who remember their own impermanence often leave behind the strongest legacy. Not because they were feared. But because they were respected. Not because they were powerful. But because they made others feel valued. At the end of the day, very few people will remember our designation. But they will always remember how we made them feel. That, perhaps, is the real leadership lesson behind Memento Mori. #Leadership #Humility #LeadershipLessons #EmotionalIntelligence #ExecutivePresence #Culture #GrowthMindset #hrmusings #nandinivijaisimha

May 2026
LinkedIn

Pennsylvania is suing Character.AI after chatbot characters allegedly presented themselves as licensed medical professionals, including psychiatrists. In one case, a chatbot allegedly claimed to be licensed in Pennsylvania and gave an invalid licence number. Accuracy is only one part of the problem but the harder issue is representation. If an AI system can make a user believe they are interacting with a licensed professional, the governance question changes: What was the AI allowed to claim about itself? What professional-status language was blocked, monitored or escalated? And who owned that interaction once the user relied on it? As AI systems move into triage, support, advice, drafting and investigation workflows, organisations will need to evidence more than “a human was available” or “the model has guardrails”. Instead of asking “was AI used?” The question has moved to: “what did the AI lead the user to believe?” #AIGovernance #AIAccountability #HealthTech #AIRegulation #DigitalTrust

May 2026

About this data. MMS (mmsholdings.com). Department attribution is 43.75%; remaining activity is grouped under Others. Updated 2026-10-03T14:00:03.490Z.

Not yet computedPer-team narrative summaries